Industries > Pharma > Fractional Flow Reserve Market Report 2019-2029

Fractional Flow Reserve Market Report 2019-2029

Forecasts by Technology (Invasive Monitoring (Pressure Guidewires, FFR Measurement Systems), Non-Invasive Monitoring), by Application (Single-Vessel Diseases, Multi-Vessel Diseases) Plus Analysis of Leading Companies

PAGES: 127
PRODUCT CODE: PHA0633
SUBMARKET:

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0633 Category: Tag:

Leading companies featured in this report are Abbott, Koninklijke Philips N.V., Boston Scientific Corporation, Acist Medical Systems (Subsidiary of Bracco Diagnostic Inc), Opsens, Heartflow, Inc., Siemens Healthineers, Pie Medical Imaging, Cathworks, and Medis Medical Imaging Systems Bv.

Fractional Flow Reserve Market Report 2019-2029, By Technology
– Invasive Monitoring
– Pressure Guidewires
– FFR Measurement Systems
– Non-Invasive Monitoring

Fractional Flow Reserve Market Report 2019-2029, By Application
– Single-Vessel Diseases
– Multi-Vessel Diseases

Fractional Flow Reserve Market Report 2019-2029, By Region
– North America
– Europe
– Asia Pacific
– Rest of the World

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Fractional Flow Reserve Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Fractional Flow Reserve Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category